These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 8774759

  • 1. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
    [Abstract] [Full Text] [Related]

  • 2. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y, Fujita K, Miyazaki Y, Takaoka M, Morimoto S.
    J Cardiovasc Pharmacol; 1995 Apr; 26 Suppl 3():S456-8. PubMed ID: 8587444
    [Abstract] [Full Text] [Related]

  • 3. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S.
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [Abstract] [Full Text] [Related]

  • 4. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
    Matsumura Y, Hashimoto N, Fujita K, Morimoto S.
    Eur J Pharmacol; 1997 Jan 14; 319(1):65-9. PubMed ID: 9030899
    [Abstract] [Full Text] [Related]

  • 5. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Eur J Pharmacol; 1995 Jul 14; 280(3):311-6. PubMed ID: 8566099
    [Abstract] [Full Text] [Related]

  • 6. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 Jul 14; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 7. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M.
    Hypertension; 1999 Feb 14; 33(2):759-65. PubMed ID: 10024341
    [Abstract] [Full Text] [Related]

  • 8. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS, Larivière R, Schiffrin EL.
    Hypertension; 1994 Aug 14; 24(2):183-8. PubMed ID: 8039842
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL, Sventek P, Li JS, Turgeon A, Reudelhuber T.
    Br J Pharmacol; 1995 Aug 14; 115(8):1377-81. PubMed ID: 8564194
    [Abstract] [Full Text] [Related]

  • 10. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS, Turgeon A, Schiffrin EL.
    Am J Hypertens; 1998 May 14; 11(5):554-62. PubMed ID: 9633791
    [Abstract] [Full Text] [Related]

  • 11. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R, Sventek P, Thibault G, Schiffrin EL.
    Can J Physiol Pharmacol; 1995 Mar 14; 73(3):390-8. PubMed ID: 7544236
    [Abstract] [Full Text] [Related]

  • 12. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
    Schiffrin EL, Larivière R, Li JS, Sventek P, Touyz RM.
    J Cardiovasc Pharmacol; 1995 Mar 14; 26 Suppl 3():S5-8. PubMed ID: 8587458
    [Abstract] [Full Text] [Related]

  • 13. Local administration of ETA (but not ETB) blockers into the PAG area of the brain decreases blood pressure of DOCA-salt rats.
    Di Filippo C, D'Amico M, Piegari E, Rinaldi B, Filippelli A, Rossi F.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug 14; 366(2):123-6. PubMed ID: 12122498
    [Abstract] [Full Text] [Related]

  • 14. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
    Schiffrin EL, Lariviere R, Li JS, Sventek P, Touyz RM.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec 14; 22(1):S188-90. PubMed ID: 9072349
    [Abstract] [Full Text] [Related]

  • 15. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M, Kobayashi Y, Yuba M, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2001 Jul 20; 424(2):121-9. PubMed ID: 11476758
    [Abstract] [Full Text] [Related]

  • 16. Effects of endothelin-1 on norepinephrine-induced vasoconstriction in deoxycorticosterone acetate-salt hypertensive rats.
    Kita S, Taguchi Y, Chatani S, Matsumura Y.
    Eur J Pharmacol; 1998 Feb 26; 344(1):53-7. PubMed ID: 9570448
    [Abstract] [Full Text] [Related]

  • 17. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD, Pollock DM, Clarke N, Fuchs LC.
    Am J Physiol; 1998 Jun 26; 274(6):R1613-8. PubMed ID: 9608015
    [Abstract] [Full Text] [Related]

  • 18. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL, Larivière R, Li JS, Sventek P.
    J Vasc Res; 1996 Jun 26; 33(3):235-48. PubMed ID: 8924521
    [Abstract] [Full Text] [Related]

  • 19. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL, Turgeon A, Deng LY.
    Br J Pharmacol; 1997 Jul 26; 121(5):935-40. PubMed ID: 9222550
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
    Sharifi AM, Schiffrin EL.
    J Hypertens; 1997 Dec 26; 15(12 Pt 1):1441-8. PubMed ID: 9431850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.